INSIGHTS ON DRUG DEVELOPMENT

• Advanced Therapies Going Mainstream: Are We There Yet?

  Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

• Strategic Early Material Generation For Accelerated Process Development

  Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

• NGS Identification Of Internal Tandem Duplications In FLT3

  Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.

• Tips And Tricks Addressing PCR Pain Points

  qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.

• Overcoming Excipient Risks And Challenges For Parenteral Formulations

  8/27/2025

  Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

• Bioanalytical Quantification Of A Biotherapeutic Peptide

  7/17/2025

  Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

• ITC: Unveiling Its Role And Importance In Drug Design

  6/26/2025

  Explore how Isothermal Titration Calorimetry empowers drug discovery, as well as learn about ITC fundamentals, how to eliminate weak candidates, and how to optimize development decisions.

• Measuring Thermodynamic Parameters In The Drug Development Process

  4/29/2025

  Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.

• The Role Of A Consulting Firm In The IND Process

  6/10/2025

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.